Skip to main content

Yun-mi Yoo

Yonsei University · Medicine

About the Lab

Professor Yun-mi Yoo's research lab specializes in pharmacoepidemiology and clinical pharmacology, focusing on the neurological and cognitive effects of commonly prescribed medications. The lab investigates the impact of drug classes such as renin-angiotensin system (RAS) inhibitors and SGLT-2 inhibitors on neurodegenerative diseases like Parkinson’s and Alzheimer’s disease, with particular attention to drug type, blood-brain barrier penetration, and treatment duration. They also examine drug-induced adverse events, including thrombocytopenia from linezolid and CNS-related side effects of opioid–gabapentinoid combinations, using large-scale health claims and electronic medical record data. Their work bridges clinical pharmacology with real-world evidence to inform safer medication use in aging and chronic disease populations.

pharmacoepidemiologyneurodegenerative diseasesdrug safetyreal-world evidenceSGLT-2 inhibitors

Research Overview

Papers
100
Total Citations
893
Papers (5y)
61
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
61total
2022
2023
2024
2025
2026
Citations per year (5y)
287total
20222023202420252026

Selected Papers

15
1
Review|179 citations·2014
Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials
Soo‐Ok Kim, Young‐Mi Ah, Yun Mi Yu, Kyung Hee Choi, WanGyoon Shin, Ju‐Yeun Lee
SJR Q1Annals of Allergy Asthma & Immunology
Food ScienceAgricultural and Biological Sciences
2
Article|56 citations·2022
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
Youngkwon Jo, Seungyeon Kim, Byoung Seok Ye, Euni Lee, Yun Mi Yu
SJR Q1Frontiers in PharmacologyOA

Background: Renin-angiotensin system (RAS) inhibitors have been suggested as protective agents in Parkinson’s disease (PD). However, epidemiological evidence on the association between RAS inhibitors and the development of PD is inconsistent. Objectives: To investigate the effect of RAS inhibitors on PD risk in patients with ischemic heart disease (IHD) by type and cumulative duration of RAS inhibitors and their degree of blood-brain barrier (BBB) penetration ability. Methods: This was a propens

Cellular and Molecular NeuroscienceNeuroscience
3
Article|55 citations·2018
Risk factors for linezolid‐induced thrombocytopenia in patients without haemato‐oncologic diseases
Go Choi, Ju‐Yeun Lee, Min Jung Chang, Young Kyung Kim, Yoonsook Cho, Yun Mi Yu, Euni Lee
SJR Q2Basic & Clinical Pharmacology & ToxicologyOA

Abstract This study aimed to describe the occurrence and to evaluate the predictive factors of thrombocytopenia caused by parenteral linezolid in hospitalised patients without haemato‐oncologic diseases. Using electronic medical records, a retrospective safety evaluation was performed among all hospitalised adult patients who received parenteral linezolid therapy between January 2005 and June 2016. Of all identified 264 patients with an average age of 63.4 ( SD 15.8) years, thrombocytopenia occu

Infectious DiseasesMedicine
4
Article|53 citations·2015
Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists
Yun Mi Yu, Wan Gyoon Shin, Ju‐Yeun Lee, Soo An Choi, Yun Hee Jo, So Jung Youn, Mo Se Lee, Kwang Hoon Choi
SJR Q1PLoS ONEOA

According to the community pharmacist reports, the leading clinical manifestations and causative drugs associated with ADRs in outpatients differed among age groups.

ToxicologyPharmacology, Toxicology and Pharmaceutics
5
Review|47 citations·2024
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, Young‐Mi Ah, Yun Mi Yu
SJR Q1Frontiers in NeuroendocrinologyOA

This systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthe

Endocrinology, Diabetes and MetabolismMedicine
6
Article|45 citations·2023
Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
Hyun Woo Lee, Seung Yeon Kim, Youngkwon Jo, You Jin Kim, Byoung Seok Ye, Yun Mi Yu
SJR Q1Frontiers in Aging NeuroscienceOA

Background Recent studies on renin-angiotensin system (RAS) inhibitors have reported a reduced risk of Alzheimer’s disease (AD). Nevertheless, the effect of RAS inhibitor type and blood–brain barrier (BBB) permeability on the risk of AD is still unknown. Objectives To assess the effects of RAS inhibitors on the risk of AD based on the type and BBB permeability and investigate the cumulative duration-response relationship. Methods This was a population-based retrospective cohort study using the K

Cardiology and Cardiovascular MedicineMedicine
7
Review|41 citations·2022
Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
Jongsung Hahn, Youngkwon Jo, So Hee Yoo, Jaekyu Shin, Yun Mi Yu, Young‐Mi Ah
SJR Q1Frontiers in PharmacologyOA

Background: The use of opioid–gabapentinoid combinations has increased, raising several safety concerns. However, meta-analysis studies focusing on this issue are limited. Objective: To evaluate the risk of central nervous system (CNS) depression, gastrointestinal (GI) adverse events, and mortality of combination therapy compared with those of opioid therapy and to explore the differences in the results according to study design and indications. Methods: Relevant studies were selected (published

Cardiology and Cardiovascular MedicineMedicine
8
Review|37 citations·2019
The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis
Gi Hyue Park, Seungyeon Kim, Min Soo Kim, Yun Mi Yu, Gun Hee Kim, Jeong Sang Lee, Euni Lee
SJR Q2International Journal of Environmental Research and Public HealthOA

Cephalosporins that contain the N-methylthiotetrazole side chain (NMTT-cephalosporin) have been reported to be associated with coagulation-related adverse events; however, a comprehensive evaluation regarding the association is lacking. A systematic review and meta-analysis were conducted to assess the safety profile of NMTT-cephalosporins with respect to hypoprothrombinemia and bleeding. The MEDLINE, Embase, Cochrane, and RISS databases were systematically searched for clinical studies up to Oc

Infectious DiseasesMedicine
9
Article|35 citations·2016
Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists
Yun Mi Yu, Euni Lee, B. Koo, Kyeong Hye Jeong, Kyung Hee Choi, Lee Kyung Kang, Mo Se Lee, Kwang Hoon Choi, Jung Mi Oh, Wan Gyoon Shin
SJR Q1PLoS ONEOA

Findings from our study showed around one in three CPs had ADR reporting experience in Korea, while 87.1% had prior experience with ADR cases. The knowledge of SR, prior experience of ADR, and less concern about the obstacles to SR were contributing factors for reporting levels.

ToxicologyPharmacology, Toxicology and Pharmaceutics
10
Article|29 citations·2019
Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit
Soyoung Kang, Jimin Park, Yun Mi Yu, Min Soo Park, Euna Han, Min Jung Chang
SJR Q1PLoS ONEOA

Antibiotics induced acute kidney injury (AKI) risk in critically ill patients is not well known. This study aimed to evaluate the AKI development and clinical outcomes in critically ill adult patients treated with vancomycin (VAN) or combined with piperacillin-tazobactam (TZP) or meropenem (MEM). This was a retrospective study on critically ill adult patients who were given VAN, TZP or MEM and maintained for at least 48 h. The risk of AKI development and clinical outcomes were compared using the

NephrologyMedicine
11
Article|27 citations·2020
Community pharmacists’ knowledge, perceptions, and practices about topical corticosteroid counseling: A real-world cross-sectional survey and focus group discussions in Korea
Min Jung Kang, Ji Hyun Park, Sunny Park, Nam Gyu Kim, Eun Young Kim, Yun Mi Yu, Do Young ‍Kim, Ju‐Yeun Lee, Wan Gyoon Shin, Soo An Choi
SJR Q1PLoS ONEOA

Topical corticosteroids (TCs) are widely used to treat dermatological conditions such as eczema and psoriasis. It can be a safe and effective treatment when used appropriately. However, misguided information and corticosteroid phobia appear to contribute to inadequate adherence to therapy, leading to unsatisfactory treatment outcomes. Therefore, community pharmacists (CPs) are in a prime position to inform patients about the appropriate use of medicine. The aim of this study was to examine how t

DermatologyMedicine
12
Article|18 citations·2017
Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients
Yun Mi Yu, Ju‐Yeun Lee, Euni Lee
SJR Q1Maturitas
SurgeryMedicine
13
Article|17 citations·2020
A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers
Seungyeon Kim, Yun Mi Yu, Myoungsoon You, Kyeong Hye Jeong, Euni Lee
SJR Q1BMC Public HealthOA

BACKGROUND: Spontaneous reporting (SR) of adverse drug reactions (ADRs) from patients can be considered as a valuable activity providing both objective and subjective data. However, improving the rate of under-reporting has been a major challenge to ensure successful operation of the SR system. This study aimed to assess knowledge, attitude, and intent to report ADRs and explore the factors contributing to consumers' reporting intent in South Korea. METHODS: Self-administered questionnaire was c

ToxicologyPharmacology, Toxicology and Pharmaceutics
14
Article|15 citations·2018
Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education
Yun Mi Yu, Seungyeon Kim, Kyung Hee Choi, Kyeong Hye Jeong, Euni Lee
SJR Q2Basic & Clinical Pharmacology & ToxicologyOA

This study aimed to determine the level of pharmacovigilance (PV) education in pharmacy programmes and to evaluate the predictive factors for the intent to report adverse drug reactions (ADRs) by pharmacy students in South Korea. Self-administered questionnaires were collected from a regionally stratified nationwide convenience sample of pharmacy students in September 2017. The association between students' intent to report ADRs and their knowledge and attitude was evaluated by using multivariat

ToxicologyPharmacology, Toxicology and Pharmaceutics
15
Article|15 citations·2023
Vitamin D supplementation for depression in older adults: a meta-analysis of randomized controlled trials
Yoonjung Park, Young‐Mi Ah, Yun Mi Yu
SJR Q1Frontiers in NutritionOA

Background In older adults, depression is associated with several other clinical problems such as cognitive impairment and low quality of life. Several studies have evaluated the relationship between vitamin D and depression in older adults; however, the results have been controversial thus far. Objective This study aimed to investigate the effects of vitamin D supplementation on depressive symptom improvement among individuals aged ≥60 years with or without a diagnosis of depression or depressi

Pathology and Forensic MedicineMedicine

Research Areas

Cardiology and Cardiovascular MedicineGeriatrics and GerontologySurgeryToxicologyNeurologyPharmacology

Dive deeper into Yun-mi Yoo's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.